Purity and identity are two different questions, answered by two different instruments. How HPLC and mass spectrometry combine to verify a research peptide batch.
Ask two questions of any research peptide: how clean is it, and is it the right molecule at all? These are different questions, and they are answered by different instruments. High-performance liquid chromatography answers the first. Mass spectrometry answers the second. A certificate of analysis with only one of them is half a verification.
Reversed-phase HPLC: the purity instrument
In reversed-phase HPLC, the dissolved sample travels through a column packed with hydrophobic stationary phase while a gradient of increasing organic solvent washes compounds off in order of hydrophobicity. A UV detector records absorbance at each moment, producing a chromatogram — a landscape of peaks. The target peptide should dominate as a single tall peak; everything else is impurity. Purity is reported as the main peak's percentage of total peak area.
What the impurities actually are
- Deletion sequences — chains missing an amino acid from a failed coupling step
- Truncated fragments — synthesis terminated early
- Diastereomers — racemized residues from harsh coupling conditions
- Residual protecting groups or scavengers carried through cleavage
For research-grade material, ≥98% main-peak area is the accepted benchmark. Below that, unknown fractions of every experimental data point are attributable to compounds that are not the peptide on the label.
Mass spectrometry: the identity instrument
Mass spec measures the mass-to-charge ratio of ionized molecules, yielding the molecular weight of whatever is in the vial. Every peptide sequence has exactly one theoretical mass. If the observed mass matches — within instrument tolerance, typically under 1 Da — the vial contains a molecule with the correct atomic composition. For acylated peptides like semaglutide, tirzepatide, and retatrutide, this is also the only routine test that confirms the fatty-acid side chain was successfully attached.
Why one test cannot substitute for the other
| Scenario | HPLC Result | MS Result | Verdict |
|---|---|---|---|
| Correct, clean peptide | ≥98% single peak | Mass matches | Verified |
| Correct peptide, dirty synthesis | 85% purity, multiple peaks | Mass matches | Fails purity |
| Wrong peptide, clean synthesis | 99% single peak | Mass does not match | Fails identity |
| Mix of similar peptides | Overlapping peaks | Multiple masses | Fails both |
The third row is the important one: a vial of entirely the wrong compound can produce a beautiful HPLC purity number. Purity without identity is how mislabeled research material passes casual inspection.
Beyond the two core tests
For cell-culture or in vivo research applications, two additional assays matter: endotoxin testing (LAL assay), since bacterial endotoxin from synthesis water can confound immunological endpoints, and counterion quantification, since trifluoroacetate counterions from HPLC purification can themselves be bioactive at high enough fractions. OLEA batch documentation reports both where applicable.
